Collegium Pharma (COLL) Stock Price, Quote & News

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 713 3699

Website: www.collegiumpharma.com

Address:

100 Technology Center Drive, Suite 300, Stoughton, United States

jewell69 Mar. 6 at 7:39 PM

$BEAM day trade 3/6 03/06/2026 Sell Edit cost basis method BEAM BEAM THERAPEUTICS INC 50 $26.7234 $0.01 $1,336.16 More 03/06/2026 Buy BEAM BEAM THERAPEUTICS INC 50 $26.30 -$1,315.00 More Total $0.01 $21.16 bottom line profit we will be selling $ADBE and $COLL on a mkt on close basis (just 50 shares each; day trading with an eye dropper )

0 · Reply

jewell69 Mar. 6 at 5:43 PM

buying on the dip with an eye dropper 03/06/2026 Buy ADBE ADOBE INC 6 $278.88 -$1,673.28 More 03/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 50 $36.74 -$1,837.00 More 03/06/2026 Buy BEAM BEAM THERAPEUTICS INC 50 $26.30 -$1,315.00 $ADBE $COLL $BEAM fwiw I didn't buy $CDNS at 297.xx new topic: 2 days ago Iran missle launches down 73% today 3/6/26 Iran missle launches down 90%

0 · Reply

Tfizzle Mar. 6 at 12:35 PM

$COLL gap down. Gap N Go? Rsi too low to ignore

0 · Reply

jewell69 Mar. 6 at 12:16 AM

$COLL 5/5 after hours GTC b 50 at 36 Close was -5.88% today 37.xx

1 · Reply

Tfizzle Mar. 5 at 10:00 PM

$HLNE $WHR $REGN awesome day. Stalking $COLL for tomorrow

0 · Reply

Tfizzle Mar. 5 at 9:05 PM

$COLL on radar for tomorrow

0 · Reply

BillionerOfKing Mar. 5 at 3:24 AM

$COLL Current Stock Price: $39.55 Contracts to trade: $40.0 COLL Mar 20 2026 Call Entry: $7.66 Exit: $14.19 ROI: 85% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

jewell69 Feb. 28 at 10:56 PM

$COLL earnings miss 2.04 vs 2.328 (missed it by 12.37% at least two firms cut pt, "por eso, no me gusto" "no toca"

0 · Reply

jewell69 Feb. 26 at 6:20 PM

$COLL last trade 2/26 1:19 pm est 44.11

0 · Reply

jewell69 Feb. 26 at 5:40 PM

$COLL just now 12:38 pm est, placed a b 80 mkt on close right now: last trade 44.09 b a 44.02 x .17 so far hi lo 4 the day 45.18 41.00 LIVING IN LUXURY ON THE PAIN AND SUFFERING OF OTHERS. previous b 20 44.30 2/23/26 today is 2/26

0 · Reply

Collegium Pharmaceutical, Inc. (COLL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 5, 2026, 8:00 AM EST - 10 days ago

Collegium to Present New Real-World Data at PainConnect 2026

Mar 2, 2026, 8:00 AM EST - 13 days ago

Collegium to Participate in Upcoming Investor Conferences

Feb 26, 2026, 5:37 PM EST - 17 days ago

Collegium Pharmaceutical, Inc. (COLL) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 7:30 AM EST - 17 days ago

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Jan 21, 2026, 10:45 PM EST - 7 weeks ago

Collegium Pharmaceutical: Buying The Projected Growth For 2026

Jan 15, 2026, 8:00 AM EST - 2 months ago

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Jan 8, 2026, 8:00 AM EST - 2 months ago

Collegium Provides 2026 Financial Guidance and Business Update

Dec 30, 2025, 8:00 AM EST - 2 months ago

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Nov 10, 2025, 4:27 PM EST - 4 months ago

Collegium Pharmaceutical: Another Solid Quarter

Nov 6, 2025, 10:06 PM EST - 4 months ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:30 AM EST - 4 months ago

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

Oct 30, 2025, 5:15 PM EDT - 4 months ago

Knight Therapeutics Announces Launch of JORNAY PM™ in Canada

Oct 23, 2025, 8:00 AM EDT - 5 months ago

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 8:00 AM EDT - 5 months ago

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

Oct 13, 2025, 8:00 AM EDT - 5 months ago

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Sep 8, 2025, 5:03 PM EDT - 6 months ago

Collegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 25, 2025, 8:00 AM EDT - 7 months ago

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Aug 7, 2025, 2:00 PM EDT - 7 months ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:30 AM EDT - 7 months ago

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Jul 24, 2025, 8:00 AM EDT - 8 months ago

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 8:00 AM EDT - 8 months ago

Collegium Announces $150 Million Share Repurchase Program

Jun 30, 2025, 2:53 PM EDT - 9 months ago

Collegium Pharmaceutical: Stock Deserves A "Buy" Call On Undervaluation Of ADHD Drug

May 12, 2025, 8:05 AM EDT - 10 months ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 9, 2025, 2:04 AM EDT - 11 months ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:01 PM EDT - 11 months ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Apr 24, 2025, 8:00 AM EDT - 11 months ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 10, 2025, 6:57 PM EDT - 1 year ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Mar 9, 2025, 4:07 AM EDT - 1 year ago

Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025

Feb 27, 2025, 9:03 PM EST - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

Collegium Provides 2025 Financial Guidance and Business Update

Nov 26, 2024, 8:00 AM EST - 1 year ago

Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion

Nov 14, 2024, 4:30 PM EST - 1 year ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 8, 2024, 12:30 AM EST - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 1 year ago

Collegium Reports Record Third Quarter 2024 Financial Results

Aug 30, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 9:30 PM EDT - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Collegium Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 6:00 AM EDT - 1 year ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

May 29, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in Jefferies Global Healthcare Conference

May 13, 2024, 8:00 AM EDT - 1 year ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 9, 2024, 7:32 PM EDT - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:02 PM EDT - 2 years ago

Collegium Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

jewell69 Mar. 6 at 7:39 PM

0 · Reply

jewell69 Mar. 6 at 5:43 PM

0 · Reply

Tfizzle Mar. 6 at 12:35 PM

$COLL gap down. Gap N Go? Rsi too low to ignore

0 · Reply

jewell69 Mar. 6 at 12:16 AM

$COLL 5/5 after hours GTC b 50 at 36 Close was -5.88% today 37.xx

1 · Reply

Tfizzle Mar. 5 at 10:00 PM

$HLNE $WHR $REGN awesome day. Stalking $COLL for tomorrow

0 · Reply

Tfizzle Mar. 5 at 9:05 PM

$COLL on radar for tomorrow

0 · Reply

BillionerOfKing Mar. 5 at 3:24 AM

0 · Reply

jewell69 Feb. 28 at 10:56 PM

$COLL earnings miss 2.04 vs 2.328 (missed it by 12.37% at least two firms cut pt, "por eso, no me gusto" "no toca"

0 · Reply

jewell69 Feb. 26 at 6:20 PM

$COLL last trade 2/26 1:19 pm est 44.11

0 · Reply

jewell69 Feb. 26 at 5:40 PM

0 · Reply

StocktwitsEarnings Feb. 26 at 12:39 PM

$COLL Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.54 up 38.46% YoY • Reported revenue of $205.45M up 12.92% YoY • Collegium Pharmaceutical's Board authorized a new share repurchase program in July 2025 for up to $150M of common stock through December 31, 2026, which will depend on cash balances and future capital requirements.

0 · Reply

OfficialStocktwitsUser Feb. 25 at 11:48 PM

$COLL RSI: 35.66, MACD: -0.3853 Vol: 1.02, MA20: 46.00, MA50: 46.91 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

jewell69 Feb. 24 at 2:23 AM

$COLL So easy, even a caveman can do it 02/23/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 20 $44.30 -$886.00 More 01/09/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 40 $46.04 $0.01 $1,841.59 More 01/09/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 40 $45.29 -$1,811.60 More 10/03/2025 Sell COLL COLLEGIUM PHARMACEUTICAL 200 $34.70 $0.03 $6,939.97

0 · Reply

ZacksResearch Feb. 19 at 4:34 PM

$COLL earnings incoming — is this the quarter bulls have been waiting for? 👀 Strong demand for Jornay PM and higher pain portfolio sales are fueling expectations heading into the Feb. 26 Q4 report. Momentum in core products is setting the tone — now it’s about execution. Will the numbers back up the optimism? Discover what’s in the cards 👉 https://www.zacks.com/stock/news/2872151/collegium-pharmaceutical-to-report-q4-earnings-whats-in-the-cards?cid=sm-stocktwits-2-2872151-teaser-34265&ADID=SYND_STOCKTWITS_TWEET_2_2872151_TEASER_34265

0 · Reply

ZacksResearch Feb. 19 at 3:34 PM

$COLL Q4 earnings preview: Can Jornay PM drive another revenue boost? 📈 Collegium's Q4 revenues are expected to be fueled by strong performance of Jornay PM and a likely increase in its pain portfolio sales. However, with an Earnings ESP of -2.43% and a Zacks Rank #3, an earnings beat may not be on the cards this time. Discover the full outlook here 👉 https://www.zacks.com/stock/news/2872151/collegium-pharmaceutical-to-report-q4-earnings-whats-in-the-cards?cid=sm-stocktwits-2-2872151-body-34264&ADID=SYND_STOCKTWITS_TWEET_2_2872151_BODY_34264

0 · Reply

EmotionlessMarket Feb. 18 at 3:29 PM

$COLL Collegium Pharmaceutical is a specialty pharma company with stable opioid-related cash flows. Growth depends on portfolio expansion and disciplined capital allocation. Regulatory risk remains a long-term overhang.

0 · Reply

Estimize Feb. 18 at 2:18 PM

Wall St is expecting 2.14 EPS for $COLL Q4 [Reporting 02/26 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

jewell69 Feb. 13 at 3:07 PM

$COLL placed a sell 300 on a mkt on close order 2/13/26 now at 10;06 am est the b a is 45.51 x .60 last trade 45.53 high so far for the day 45.84; 45.28 is the low so for the day as of 10:06 am est

1 · Reply

jewell69 Feb. 11 at 7:36 PM

$COLL 2/10 B 300 44.56 2/11 B 300 44.69 2/11 S 300 45.39 ALL done in an ira. I still own 300 "living in luxury on the pain and suffering of others" they sell non-addictive opiods.

0 · Reply

jewell69 Feb. 11 at 5:36 PM

$COLL doubling down b yesterdday 2/10 300 b 300 more on bad down day -4.58% on ?? good ?? news ?? Truist Adjusts Price Target on Collegium Pharmaceutical to $58 From $55, Maintains Buy Rating

1 · Reply

jewell69 Feb. 10 at 4:11 PM

b $CPS 34.85 stifel focus list b $COLL 46.05 trying 2 add on to $XLY 118.40 at 11 am est on 2/10 119.07 x .08 previous buy 2/6 117.56 and .70 in variable annuity went from cash to $XLK clone. I will get 2/10 closing price. Money came from $IYZ clone, ugh !

0 · Reply

jewell69 Feb. 10 at 1:34 AM

IN LUXURY ON THE PAIN AND SUFFERING OF OTHERS ! they sell non-addictive opiods. $COLL the "post-modern high" close 12/29 49.52 2/9/26 close 46.28 (-2.79% for today) 11/5/25 close ONLY 35.09; b4 blowout earns 2.25 vs 2.044 estimated this looks better than $BKNG to say the least tip ranks 4 out of 4 say buy. pts of 58 cut to 56 ugh! 46 raised to 60 55 48 raised to 56 me? 11/6/25 s 51 at 40.05 other acct. 1/9/26 day trade b and sell b just 40 shares 45.29 s 40 at 46.04

0 · Reply

Market Cap	1.10B
Revenue (ttm)	780.57M
Net Income (ttm)	62.87M
EPS (ttm)	N/A
PE Ratio	5.22
Forward PE	5.27
Profit Margin	8.05%
Debt to Equity Ratio	1.89

Volume	413,400
Avg Vol	461,400
Day's Range	N/A - N/A
Shares Out	31.75M
Stochastic %K	3%
Beta	0.67
Analysts	Strong Sell
Price Target	$53.83